| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-08 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
6e-08 |
| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-07 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
5e-07 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-05 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |